Masimo | MASI - Le Bénéfice D'Exploitation

Prix De L'Action
178.63
Variation Quotidienne
-0.08 -0.04%
Mensuellement
0.30%
Annuel
9.09%
Q2 Prévisions
174.81




Le Bénéfice D'Exploitation Changement Date
Abbott USD 1.85B 399M 2026-03
Accuray USD 4.71M 6.86M 2024-12
Align Technology USD 224.71M 40.06M 2025-12
AngioDynamics USD -2.51M 5.41M 2025-09
Artivion USD 4.79M 6.85M 2025-12
AtriCure USD 2.49M 2.28M 2025-12
Avanos Medical USD 24.77M 5.8M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Boston Scientific USD 1.24B 203M 2025-12
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 514.7M 144.4M 2026-03
General Electric Aerospace USD 2.32B 549M 2026-03
Globus Medical USD 181.31M 298.83M 2025-12
Haemonetics USD 67.4M 8.9M 2025-12
Inogen USD -7.79M 728K 2024-09
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 859.7M 5.6M 2026-03
Masimo USD 83.9M 300K 2025-12
Medtronic USD 1.74B 40M 2025-12
Orthofix International USD 6.12M 1.91M 2025-12
Owens Minor USD 814K 28.08M 2025-12
ResMed USD 497.6M 35.25M 2025-12
Steris USD 278M 7.1M 2025-12
Stryker USD 1.97B 609M 2025-12
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 445.24M 2025-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12